CARIS LIFE SCIENCES, INC. (CAI) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $283.00K; Additional Paid in CapitalUSD $3.14B; Treasury Stock, Common, ValueUSD $0.00.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $284.00K; Additional Paid in CapitalUSD $3.16B; Treasury Stock, Common, ValueUSD $16.90M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $283.00K; Additional Paid in CapitalUSD $3.14B; Treasury Stock, Common, ValueUSD $16.90M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $283.00K; Additional Paid in CapitalUSD $3.12B; Treasury Stock, Common, ValueUSD $16.92M.
CARIS LIFE SCIENCES, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | Treasury Stock, Retired, Cost Method, Amount USD | Treasury Stock, Shares, Retired shares | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD | Treasury Stock, Shares, Acquired shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $283.00K | $3.14B | $0.00 | $529.00K | $-2.55B | $591.73M | 0.00 | 3 month · $21.38M 6 month · $21.38M | 3 month · $0.00 6 month · $0.00 | 1 month · 1.61M | (m) | 3 month · $22.22M 6 month · $38.09M | (m) | (m) |
| 2026-03-31 | $0.00 | $284.00K | $3.16B | $16.90M | $893.00K | $-2.55B | $593.49M | 1.61M | (m) | (m) | (m) | (m) | 3 month · $15.87M | (m) | (m) |
| 2025-12-31 | $0.00 | $283.00K | $3.14B | $16.90M | $936.00K | $-2.55B | $577.31M | 1.61M | 12 month · $16.57M | (m) | (m) | (m) | 12 month · $70.01M | 12 month · $85.43M | 12 month · 1.43M |
| 2025-09-30 | $0.00 | $283.00K | $3.12B | $16.92M | $748.00K | $-2.63B | $478.36M | 1.62M | 9 month · $16.59M | (m) | (m) | (m) | 3 month · $13.65M 9 month · $56.64M | 9 month · $85.43M | 9 month · 1.44M |
| 2025-06-30 | $0.00 | $282.00K | $3.12B | $16.92M | $669.00K | $-2.66B | $452.90M | 1.62M | 6 month · $16.59M | (m) | (m) | (m) | 3 month · $28.29M 6 month · $42.98M | 3 month · $60.97M 6 month · $85.43M | 6 month · 1.44M |
| 2025-06-20 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $9.00M | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-2.60B | (m) | 3 month · $16.59M | (m) | (m) | (m) | 3 month · $14.69M | 3 month · $24.46M | (m) |
| 2024-12-31 | $0.00 | $38.00K | $0.00 | $330.00K | $210.00K | $-2.47B | $-2.50B | 182.50K | (m) | (m) | (m) | (m) | 12 month · $18.64M | 12 month · $96.37M | 12 month · 0.00 |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | $-2.44B | (m) | (m) | (m) | (m) | (m) | 3 month · $4.72M 9 month · $13.67M | 3 month · $24.66M 9 month · $71.37M | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | $-2.36B | (m) | (m) | (m) | (m) | (m) | 3 month · $4.49M 6 month · $8.94M | 3 month · $23.59M 6 month · $46.71M | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-2.27B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-2.14B | (m) | (m) | (m) | (m) | (m) | 12 month · $15.24M | 12 month · $121.11M | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-1.70B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |